New asthma injection shows promise in early trial
Disease control
Completed
This early-phase study tested a new drug called RC1416 in 40 adults with moderate to severe asthma. Participants received a single injection of either the drug or a placebo. The main goal was to check safety and how the body processes the drug, with a preliminary look at whether …
Phase: PHASE1 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC